泚å°ãšèããšäœãæãåºãã ããããä»ã®ã³ããçŠã§é²ããããŠããCOVID-19ã®ã¯ã¯ãã³æ¥çš®ã ããããã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ã ããããç®è¡ã ãããããããšãæ¯å»è ã§ã®ææ¯ãªã©ã§ã®éº»é 泚å°ã ããããã¿ãªãããæãæµ®ãã¹ãã·ãŒã³ã¯ç°ãªããããããªãã
äžèšã«åºããäŸã¯ã泚å°éãäœã«åºããè¬æ¶²ãªã©ãæ³šå ¥ãããã¯è¡æ¶²ãæ¡åãããæ³šå°ãšããã®ã¯ãâéãäœã«åºããâã®ã ãããã¯äžèŠããæããããŸããŸãªæè¡éçºã»æ¹è¯ããªãããŠããã ããããçè ãåäŸã®ãããšå€§ããå€ãã£ãŠããªãããããªå°è±¡ãåããã®ã¯ãããã ãã ãããã
ãããŠèª°ãããããã®éã«é¢ããŠãªã«ãããã®èŠçãèšæ¶ã«ããã®ã§ã¯ãªãã ããããå®ã¯ããã®èŠçããªããªãããããªéã®ãªã泚å°åšãäžã®äžã«ã¯ååšãããã§ã¯ããã®éã®ãªã泚å°åšãšã¯ã©ã®ãããªãã®ãªã®ããããããªããä»ãªãããŸãèŠãããªãã®ãããããªè©±é¡ã«ã€ããŠç޹ä»ããããšæãã
éã®ãªã泚å°åšãšã¯
éã®ãªã泚å°åšãšã¯ããã®åã®ããšãâéâããªãã®ã§ãéãäœã«æããšããæ£è ã«å¯ŸããŠã®å¿ççãèäœçãªè² æ ãæžããããšãã§ãã倧ããªã¡ãªãããããã
ã»ãã«ãå»çäºæ ãææçããããŠå»ç廿£ç©ãªã©ãå€§å¹ ã«äœæžããããšãã§ããããããªã¡ãªãããããã®ã ãã§ã¯ãéã®ãªã泚å°åšã«ã€ããŠç޹ä»ããŠãããã
ãŸããæ±å倧åŠè¥¿æŸ€æŸåœŠææãéçºããããã€ã¯ãããŒãã«ãã³ãããâ貌ãâã¿ã€ãã®æ³šå°åšã ãäžå³ã®å³ã«åç¶å ã«å°ããªçªèµ·äžã®ãã®ã確èªã§ããã ãããããããå€åæ§ã®ããŒã©ã¹ãã€ã¯ãããŒãã«ããããŠã黿°ã§é»æ°æµžéæµãçºçãããããšã§ãè¬æ¶²ãªã©ã®æ³šå ¥éãšæ³šå ¥é床ãå¢å ãããããšãã§ãããŸãç®äžçµç¹æ¶²ã®é«éæ¡åãå¯èœã«ããŠããã
ã»ãã«ãã¢ã¡ãªã«ã®Portal Instrumentsâ»1ã¯ãäžå³ã®éã®ãªã泚å°åšã販売ããŠãããPortal Instrumentsã¯ãããµãã¥ãŒã»ããå·¥ç§å€§åŠ(MIT)ã®ã¹ãã³ã¢ãŠãã§ãéã®ãªãäžçã®å®çŸãç®æããŠããã
圌ãã®éçºããéã®ãªã泚å°åšã¯ã人ã®é«ªã®æ¯ãããã®çްãã®ãžã§ããåŽå°ã圢æããããšã§ãè¬ç©ãç®èã®äžãžãšæ³šå ¥ããããã®æ³šå ¥ããã£ã0.4ç§ã§å®äºãããšããããã®éã®ãªã泚å°åšã¯ãè¬ç©ãç®è衚é¢ãšçèã®éã®çµç¹ã®ç®äžå±€ã«å ¥ãããã«ãè¬æ¶²ã®å§åãé床ãå¶åŸ¡ããããããã°ã©ãã³ã°ãããŠãããšããã å®éã«ãã®éã®ãªã泚å°åšã¯ãç¡æãå§è¿«æããããã£ããæããªã©ã®æèŠãããããã ã
ãããšé¡äŒŒãããã®ãšããŠã¯ãã¢ã€ãžã§ãã¯ã¹ã»ãã¡ãŒãã€ã³ã¿ãŒãã·ã§ãã«â»2ã®ãInjex50ããšããéã®ãªã泚å°åšããããäœã«éãåºãããšãã埮现ãªãžã§ããæµã§è¬æ¶²ãç®äžæ³šå°(ç®äžçµç¹ã«è¬ç©ãæ³šå ¥ããæ³šå°)ã§ããæ£è ã®éã®çã¿ãåãããããšãã§ããã
ãŸããä¹å·å€§åŠã®å±±è¥¿éœåææâ»3ã¯ãé«éã§çºå°ããæ°æ³¡ãã¯ãããåã§ç®èã«åŸ®çްãªç©Žã空ãããã®ç©Žããã詊è¬ããŸãšã£ãåŸ®çŽ°ãªæ°æ³¡ãæ³šå ¥ããããšãã§ããéã®ãªã泚å°åšãéçºããŠããã
ããã¯ãããã€ã¯ãããã«ã€ã³ãžã§ã¯ã·ã§ã³ã¡ã¹ããšããæè¡ãæ¹è¯ãããã®ã§ã以åã®éãªã泚å°åšã§ããã°ç¥çµãå·ã€ããæãããå€å°ã®çã¿ãæããå¯èœæ§ãæé€ãããã®ã ã
ä»ã«ãããã®éã®ãªã泚å°åšã«é¢ããŠæ§ã ãªç ç©¶è ãäŒæ¥ãäžçã«ã¯ååšãããå šãŠã玹ä»ããããšãã§ããªãã®ã§ããã®çšåºŠãšãããŠããã ãããããå®ã¯éã®ãªã泚å°åšã¯ä»¥åããååšããŠãããšãããããããè¬æ¶²ã®æµžéãè¬æ¶²æ³šå ¥ã®é床ãå§åãªã©ã®å¶åŸ¡é¢ã®æè¡éçºã補é ã³ã¹ãã®é¢ã§ããŸãæ®åããŠããªããããã宿 ã®ããã ã
éã®ãªã泚å°åšã¯ç®äžæ³šå°ã¿ããã ãã©ãçèæ³šå°ã代æ¿ã§ããã®!?
èªè ã®ãªãã§ããããªçåãæã£ãããã¯ããã£ããããªãã ãããã
äžèšã®éã®ãªã泚å°åšã¯ãç®äžæ³šå°ã«è©²åœãããã§ãçèæ³šå°ã¯ãé·ãéãäœã®çèã®ããæ·±éšãŸã§æã泚å°ã ãããã®éã®ãªã泚å°åšã§ã¯ãã®åœ¹å²ãæãããã®ã ãããã
çè ã¯å»çã®å°éå®¶ã§ã¯ãªãã®ã§è©³çްã¯åãããããããææ¥æ°èã®èšäºã§é äºå¥åžå»åž«ã次ã®ããã«è¿°ã¹ãŠããâ»4ãæ¥æ¬ã§ã¯ãæŽå²çãªèæ¯ããç®äžæ³šå°ãäž»ã«å®æœãããçŸåšããã®æé»çãªã«ãŒã«ãæ®ã£ãŠããããããããã®ç®äžæ³šå°ã¡ã€ã³ãšããæ¥æ¬ç¬èªã®ããŒã«ã«ã«ãŒã«ã¯ç¹ã«å»åŠçãªæ ¹æ ãšãããã®ããªããããã
ä»åã®COVID-19ã®ã¯ã¯ãã³æ¥çš®ã¯ãæµ·å€ç±æ¥ã®ããçèæ³šå°ãšãªã£ãŠãããæ°åã³ããã¯ã¯ãã³ãç®äžæ³šå°ãããšãã®å®å šæ§ãæå¹æ§ã®ããŒã¿ããªãã®ã§ãç®äžæ³šå°ãšããéžæè¢ããªãã ãã®ããã ã
ã€ãŸããç®äžæ³šå°ãçèæ³šå°ãæå¹æ§ãããã°ã©ã¡ãã§ããããšããå°è±¡ã ãå æ¥ã倧éªå€§åŠãšåµè¬ãã³ãã£ãŒã®ã¢ã³ãžã§ã¹ãéãªã泚å°åšã§COVID-19ã®ã¯ã¯ãã³æ¥çš®ã®æ²»éšã宿œãããšå ±ããã®ããã®äŸã ããã
ãããã ã£ãã ããããä»åã¯ãéã®ãªã泚å°åšã«ã€ããŠç޹ä»ãããããã»ã©é ããªãæªæ¥ã«ãããŠã確å®ã«ãã®éã®ãªã泚å°åšãäž»æµãšãªãã ããããããªæªæ¥ãæåŸ ãããã
åèæç®
â»1https://www.portalinstruments.com/
â»2https://aijexpharma.jp/
â»3https://bmf.mech.kyushu-u.ac.jp/
â»4https://www.asahi.com/articles/ASP1Q3514P1PUBQU005.html

